Login to Your Account



Merck Scientists Fabricate PSA Compound To Treat Testosterone- Refractory End-Stage Malignancy


Wednesday, November 15, 2000
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription